PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.75%
Revenue growth of 1.75% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
1.77%
Gross profit growth of 1.77% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
4.04%
EBIT growth exceeding 1.5x Healthcare median of 2.36%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
15.41%
Operating income growth exceeding 1.5x Healthcare median of 2.52%. Joel Greenblatt would see if unique processes drive exceptional profitability.
13.61%
Net income growth exceeding 1.5x Healthcare median of 3.33%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
13.59%
EPS growth exceeding 1.5x Healthcare median of 6.16%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
13.59%
Diluted EPS growth exceeding 1.5x Healthcare median of 6.60%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
0.02%
Share reduction exceeding 1.5x Healthcare median of 0.21%. Joel Greenblatt would applaud significant buybacks if they are value-accretive.
0.02%
Diluted share reduction exceeding 1.5x Healthcare median of 0.20%. Joel Greenblatt would see a meaningful advantage if shares are undervalued.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while Healthcare median is 6.23%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-100.00%
Negative FCF growth while Healthcare median is 7.29%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
160.73%
10Y CAGR of 160.73% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
56.92%
5Y CAGR of 56.92% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
34.46%
3Y CAGR of 34.46% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
138.65%
Net income/share CAGR exceeding 1.5x Healthcare median of 15.52% over a decade. Joel Greenblatt might see a standout compounder of earnings.
37.21%
5Y net income/share CAGR > 1.5x Healthcare median of 9.24%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
-32.24%
Negative 3Y CAGR while Healthcare median is 6.31%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
331.44%
Equity/share CAGR of 331.44% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
86.25%
5Y equity/share CAGR of 86.25% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
35.83%
3Y equity/share CAGR of 35.83% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
166.67%
5Y dividend/share CAGR of 166.67% while Healthcare is zero. Walter Schloss sees at least some improvement that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
9.04%
AR growth of 9.04% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
-3.29%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
-1.36%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
1.52%
Positive BV/share change while Healthcare median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
-6.02%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-0.62%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.